The manufacturing execution system in life sciences market size is projected to reach US$ 10,456.54 million by 2033 from US$ 3,139.14 million in 2022. The market is expected to register a CAGR of 12% during 2023–2033. A shift from legacy to modern MES is likely to remain a key trend in the market.
Manufacturing Execution System in Life Sciences Market Analysis
Modern MES solutions are embracing more aspects of enterprise resource planning (ERP) platforms. This allows them to offer better logistics tracking, material identity, and integration with the production operations, together with a distributed model that surpasses traditional production. Moreover, traditional MES solutions are focused on batch manufacturing and are often incapable of necessary capabilities without significant customization. In the forecast period, such factors are expected to promote the adoption of modern manufacturing execution systems among life science researchers.
Manufacturing Execution System in Life Sciences Market Overview
The manufacturing execution system (MES) is a dynamic, comprehensive solution that helps track, document, monitor, and control the process of manufacturing goods, from raw materials to finished products. These solutions also provide the decision-makers with multivariate data that can be utilized to optimize plant floor operations and enhance production efficiency. MES can have extended functionalities, typically referred to as manufacturing operations management (MOM) functions. The term “manufacturing operations management” is defined as Level 3 of the ANSI/ISA-95 Enterprise-Control System Integration standard.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Manufacturing Execution System in Life Sciences Market: Strategic Insights
Market Size Value in US$ 3,139.14 million in 2022 Market Size Value by US$ 10,456.54 million by 2033 Growth rate CAGR of 12.0% from 2023 to 2033 Forecast Period 2023-2033 Base Year 2022
Naveen
Have a question?
Naveen will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Manufacturing Execution System in Life Sciences Market: Strategic Insights
| Market Size Value in | US$ 3,139.14 million in 2022 |
| Market Size Value by | US$ 10,456.54 million by 2033 |
| Growth rate | CAGR of 12.0% from 2023 to 2033 |
| Forecast Period | 2023-2033 |
| Base Year | 2022 |
Naveen
Have a question?
Naveen will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Manufacturing Execution System in Life Sciences Market Drivers and Opportunities
Requirement of Accurate Real-Time Data in Production Management Process
MES can help manufacturers function with a lower workforce, gather accurate real-time data from the production process, increase process efficiency and flexibility, safeguard regulatory expectations, and digitize the manufacturing process.
In February 2022, Integerannounced that it had acquired Critical Manufacturing's Manufacturing Execution System (MES) to enhance the efficiency and quality of its global production processes. The company will utilize this module at its site in Ireland to digitize its production processes, gather real-time data, and enhance efficiency, quality, and traceability. Similarly, in September 2020, Körber and Walvax Biotechnology announced that it had signed an agreement to implement Werum PAS-X MES, the MES for pharma, biotech, and cell & gene therapy manufacturing, at its Yuxi plant for vaccine production. As per Körber, PAS-X MES allows the user to manage, visualize and analyze data fast, comprehensively, and in real time. In August 2019, Takeda Ireland Ltd. implemented PAS-X MES in a phased approach at its Grange Castle, Ireland, production site and transformed it into a paperless factory. Such growing adoption of MES by the market players for gathering accurate real-time data in the production management process is boosting the growth of manufacturing execution systems in life science market. In addition, modern MES solutions (often referred to as light MES) are highly flexible, tailored as per requirements, integrate various tools, and are cloud-based. Further, the MES and Laboratory Execution Systems (LES) can also help reduce the risk of contamination, improve data integrity, lower operating costs, ensure regulatory compliance and quality, and enhance track and trace capabilities. Because of all the above advantages of using MES, various market players are adopting the system.
Rising application in cell and gene therapy manufacturing
There is also an increasing number of collaborations between key solution providers of the pharmaceutical manufacturing industry’s ecosystem for developing advanced solutions for cell and gene therapy product manufacturing. In January 2022, TrakCe collaborated with Korber for software integration. The collaboration resulted in a functional integration between TrakCel’s OCELLOS and Körber’s PAS-X. It is expected to allow both companies' cell and gene therapy customers to effectively share data detailing manufacturing events and milestones such as starting checks, fill and finish, and product release; and provide full traceability and audit logs. In October 2021, Körber and Vineti announced that they were partnering to integrate Korber’s PAS-X MES with Vineti’s industry-leading Personalized Therapy Management (PTM) platform. This partnership will further empower biopharma customers with an integrated PAS-X MES solution, which will help bring life-saving cell and gene-based therapies to patients in need. Thus, the growing application and adoption of MES by the market players in cell and gene therapy manufacturing is expected to create an opportunity for the growth of the manufacturing execution system in life science market during the forecast period.
Manufacturing Execution System in Life Sciences Market Report Segmentation Analysis
Key segments that contributed to the derivation of the manufacturing execution system in life sciences market analysis are offering, deployment, organization size and application.
- Based on the offering, the manufacturing execution system in life sciences market is divided into hardware and software. The software segment held a larger market share in 2023.
- By deployment, the market is segmented into on-premises and cloud.
- By organization size, the market is segmented into SMEs and large enterprises.
- By application, the market is segmented into pharmaceutical, biotechnology, and medical devices.
Manufacturing Execution System in Life Sciences Market Share Analysis by Geography
The geographic scope of the manufacturing execution system in life sciences market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. In North America, technological innovations are projected to offer growth opportunities for the manufacturing execution system in life science market. Further, the rising digitization of manufacturing processes in the pharmaceutical industry is fueling the growth of the manufacturing execution system in life science market in the region. In addition, the presence of market players such as Apprentice FS, Inc; Atachi Systems; Emerson Electric Co; POMS Corporation; and Rockwell Automation, which are continuously working on easing the manufacturing processes in the healthcare industry, is boosting the growth of the manufacturing execution system in life science market.
Manufacturing Execution System in Life Sciences Market Report Scope
Manufacturing Execution System in Life Sciences Market News and Recent Developments
The manufacturing execution system in life sciences market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the manufacturing execution system in life sciences market are listed below:
- Lonza and NNIT announced a partnership to accelerate MES projects. The companies will collaborate on Lonza's MODA Platform with NNIT's Accelerated Implementation Methodology. (Source: Lonza, Press Release, March 2021.)
- AVEVA, a global leader in industrial software, driving digital transformation and sustainability, expanded CONNECT, its world-leading industrial intelligence platform, with data and visualization services for hybrid Manufacturing Execution System (MES) solutions. (Source: AVEVA, Press Release, April 2023)
Manufacturing Execution System in Life Sciences Market Report Coverage and Deliverables
The “Manufacturing Execution System in Life Sciences Market Size and Forecast (2023–2033)” report provides a detailed analysis of the market covering below areas:
- Manufacturing execution system in life sciences market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Manufacturing execution system in life sciences market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- manufacturing execution system in life sciences market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the manufacturing execution system in life sciences market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Offering, Deployment, Organization Size, and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The global manufacturing execution system in life sciences market is expected to reach US$ 10,456.54 million by 2033.
The expected CAGR of the global manufacturing execution system in life sciences market is 12%.
Shift from legacy to modern MES is anticipated to play a significant role in the global manufacturing execution system in life sciences market in the coming years.
The key players holding majority shares in the global manufacturing execution system in life sciences market are Siemens AG, Emerson Electric, Schneider Electric, Rockwell Automation, Apprentice FS Inc, ATS Global, Atachi Systems, LZ Lifescience Ltd, and POMS Corporation.
North America dominates the manufacturing execution system in life sciences market.
The requirement of accurate real-time data in the production management process and rising application in cell and gene therapy manufacturing are the major factors that propel the global manufacturing execution system in life sciences market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Manufacturing Execution System in Life Sciences Market – By Offering
1.3.2 Global Manufacturing Execution System in Life Sciences Market – By Deployment
1.3.3 Global Manufacturing Execution System in Life Sciences Market – By Organization Size
1.3.4 Global Manufacturing Execution System in Life Sciences Market – By Application
1.3.5 Global Manufacturing Execution System in Life Sciences Market – By Geography
2. Manufacturing Execution System in Life Sciences Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Manufacturing Execution System in Life Sciences Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 Middle East and Africa
4.2.5 South America
4.3 Ecosystem Analysis
4.4 Expert Opinion
4.5 Premium Insights
4.5.1 MES Market Analysis, By Function
4.5.1.1 Data collection and Acquisition:
4.5.1.2 Labor Management:
4.5.1.3 Process Management:
4.5.1.4 Performance Analysis:
4.5.1.5 Document Control:
4.5.1.6 Dispatching and Production:
4.5.2 Future of MES
4.5.3 Start-Up Landscape
4.5.4 Competitive Benchmarking
4.5.5 End User/Customer’s Vision
4.5.6 Light MES: Market Analysis
4.5.6.1 Light MES in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
4.5.6.2 Light MES vs Standard MES
4.5.7 Light MES Products for Life Sciences Industry
4.5.8 Leading MES Products for Life Sciences Industry
4.5.9 MES Service Providers/System Integrators for Life Sciences Industry
4.5.10 MES Solutions Used by Major Life Sciences Companies
5. Manufacturing Execution System in Life Sciences Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Need for Compliance with Regulatory Framework
5.1.2 Requirement of Accurate Real-Time Data in Production Management Process
5.2 Market Restraints
5.2.1 High Cost and Lack of Flexibility
5.3 Market Opportunities
5.3.1 Rising Application in Cell and Gene Therapy Sector
5.4 Future Trends
5.4.1 Shift from Legacy to Modern MES
5.4.2 Rise in Adoption of Pharma 4.0
5.5 Impact Analysis of Drivers and Restraints
6. Manufacturing Execution System in Life Sciences Market – Global Analysis
6.1 Global Manufacturing Execution System in Life Sciences Market Overview
6.2 Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
6.3 Company Market Share Analysis
7. Manufacturing Execution System in Life Sciences Market Analysis – By Offering
7.1 Overview
7.2 Manufacturing Execution System in Life Sciences Market, By Offering (2022 and 2033)
7.3 Software
7.3.1 Overview
7.3.2 Software: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
7.4 Services
7.4.1 Overview
7.4.2 Services: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
8. Manufacturing Execution System in Life Sciences Market Analysis – By Deployment
8.1 Overview
8.2 Manufacturing Execution System in Life Sciences Market, By Deployment (2022 and 2033)
8.3 On-Premises
8.3.1 Overview
8.3.2 On-Premises: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
8.4 Cloud
8.4.1 Overview
8.4.2 Cloud: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
9. Manufacturing Execution System in Life Sciences Market Analysis – By Organization Size
9.1 Overview
9.2 Manufacturing Execution System in Life Sciences Market, By Organization Size (2022 and 2033)
9.3 SMEs
9.3.1 Overview
9.3.2 SMEs: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
9.4 Large Enterprises
9.4.1 Overview
9.4.2 Large Enterprises: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
10. Manufacturing Execution System in Life Sciences Market Analysis – By Application
10.1 Overview
10.2 Manufacturing Execution System in Life Sciences Market, By Application (2022 and 2033)
10.3 Pharmaceutical
10.3.1 Overview
10.3.2 Pharmaceutical: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
10.4 Biotechnology
10.4.1 Overview
10.4.2 Biotechnology: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
10.5 Medical Devices
10.5.1 Overview
10.5.2 Medical Devices: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
11. Manufacturing Execution System in Life Sciences Market Analysis – By Region
11.1 North America: Manufacturing Execution System in Life Sciences Market
11.1.1 Overview
11.1.2 North America: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.3 North America: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.4 North America: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.1.5 North America: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.1.6 North America: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.1.7 North America: Manufacturing Execution System in Life Sciences Market, by Country, 2022 & 2033 (%)
11.1.7.1 US: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.7.1.3 US: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.7.1.4 US: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.1.7.1.5 US Manufacturing Execution System in Life Sciences Market, by Organization Size, 2022–2033 (US$ Million)
11.1.7.1.6 US Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.1.7.2 Canada: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.7.2.3 Canada: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.7.2.4 Canada: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.1.7.2.5 Canada: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.1.7.2.6 Canada Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.1.7.3 Mexico: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.7.3.3 Mexico: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.7.3.4 Mexico: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.1.7.3.5 Mexico Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2 Europe: Manufacturing Execution System in Life Sciences Market
11.2.1 Overview
11.2.2 Europe: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.3 Europe: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.4 Europe: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.5 Europe: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.6 Europe: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2.7 Europe: Manufacturing Execution System in Life Sciences Market, by Country, 2022 & 2033 (%)
11.2.7.1 Germany: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.1.3 Germany: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.7.1.4 Germany: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.7.1.5 Germany: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.7.1.6 Germany Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2.7.2 France: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 France: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.2.3 France: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.7.2.4 France: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.7.2.5 France: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.7.2.6 France Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2.7.3 Italy: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 Italy: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.3.3 Italy: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.7.3.4 Italy: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.7.3.5 Italy: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.7.3.6 Italy Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2.7.4 UK: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 UK: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.4.3 UK: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.7.4.4 UK: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.7.4.5 UK: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.7.4.6 UK Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2.7.5 Spain: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.5.3 Spain: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.7.5.4 Spain: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.7.5.5 Spain: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.7.5.6 Spain Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2.7.6 Rest of Europe: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.6.3 Rest of Europe: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.7.6.4 Rest of Europe: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.7.6.5 Rest of Europe: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.7.6.6 Rest of Europe Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3 Asia Pacific: Manufacturing Execution System in Life Sciences Market
11.3.1 Overview
11.3.2 Asia Pacific: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.3 Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.4 Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.5 Asia Pacific: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.6 Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3.7 Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Country, 2022 & 2033 (%)
11.3.7.1 Australia: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 Australia: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.1.3 Australia: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.7.1.4 Australia: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.7.1.5 Australia: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.7.1.6 Australia: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3.7.2 China: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 China: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.2.3 China: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.7.2.4 China: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.7.2.5 China: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.7.2.6 China Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3.7.3 India: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.3.3 India: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.7.3.4 India: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.7.3.5 India: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.7.3.6 India: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3.7.4 Japan: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 Japan: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.4.3 Japan: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.7.4.4 Japan: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.7.4.5 Japan: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.7.4.6 Japan: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3.7.5 South Korea: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.5.3 South Korea: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.7.5.4 South Korea: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.7.5.5 South Korea: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.7.5.6 South Korea: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3.7.6 Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.4 Middle East and Africa: Manufacturing Execution System in Life Sciences Market
11.4.1 Overview
11.4.2 Middle East and Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.3 Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.4.4 Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.4.5 Middle East and Africa: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.4.6 Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.4.7 Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Country, 2022 & 2033 (%)
11.4.7.1 South Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.1.1 Overview
11.4.7.1.2 South Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.1.3 South Africa: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.4.7.1.4 South Africa: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.4.7.1.5 South Africa: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.4.7.1.6 South Africa: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.4.7.2 Saudi Arabia: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.2.1 Overview
11.4.7.2.2 Saudi Arabia: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.2.3 Saudi Arabia: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.4.7.2.4 Saudi Arabia: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.4.7.2.5 Saudi Arabia: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.4.7.2.6 Saudi Arabia: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.4.7.3 UAE: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.3.1 Overview
11.4.7.3.2 UAE: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.3.3 UAE: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.4.7.3.4 UAE: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.4.7.3.5 UAE: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.4.7.3.6 UAE: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.4.7.4 Rest of Middle East & Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East & Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.4.3 Rest of Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.4.7.4.4 Rest of Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.4.7.4.5 Rest of Middle East and Africa: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.4.7.4.6 Rest of Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.5 South America: Manufacturing Execution System in Life Sciences Market
11.5.1 Overview
11.5.2 South America: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.3 South America: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.5.4 South America: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.5.5 South America: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.5.6 South America: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.5.7 South America: Manufacturing Execution System in Life Sciences Market, by Country, 2022 & 2033 (%)
11.5.7.1 Brazil: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.7.1.1 Overview
11.5.7.1.2 Brazil: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.7.1.3 Brazil: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.5.7.1.4 Brazil: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.5.7.1.5 Brazil: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.5.7.1.6 Brazil: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.5.7.2 Argentina: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.7.2.1 Overview
11.5.7.2.2 Argentina: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.7.2.3 Argentina: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.5.7.2.4 Argentina: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.5.7.2.5 Argentina: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.5.7.2.6 Argentina: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.5.7.3 Rest of South & Central America: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.7.3.3 Rest of South America: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.5.7.3.4 Rest of South America: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.5.7.3.5 Rest of South America: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.5.7.3.6 Rest of South America: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
12. Industry Landscape
12.1 Overview
12.2 Market Initiatives, Expansions, and Strategic Developments
12.3 New Product/Feature Development
12.4 Mergers and Acquisitions
12.5 Agreements, Collaborations, and Joint Ventures
13. Company Profiles
13.1 Apprentice FS Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 ATS Global B.V.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Atachi Systems
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Emerson Electric Co
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 LZ Lifescience Limited
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Korber AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 POMS Corporation
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Rockwell Automation Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Schneider Electric SE
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Siemens AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Word Index
LIST OF TABLES
Table 1. Start-Ups
Table 2. Competitive Benchmarking (2022)
Table 3. Light MES in Life Sciences Market, By Geography – Revenue and Forecast to 2023 (US$ Million)
Table 4. Light MES vs Standard MES
Table 5. Light MES Products for Life Sciences Industry
Table 6. Leading MES Products for Life Sciences Industry
Table 7. MES Service Providers/System Integrators for Life Sciences Industry
Table 8. MES Solutions Used by Major Pharma/Biopharma Companies
Table 9. MES Solutions Used by Major Medical Device Manufacturers
Table 10. Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2023 (US$ Million)
Table 11. North America Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 12. North America Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 13. North America Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 14. North America Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 15. US Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 16. US Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 17. US Manufacturing Execution System in Life Sciences Market, by Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 18. US Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 19. Canada Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 20. Canada Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 21. Canada Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 22. Canada Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 23. Mexico Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 24. Mexico Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 25. Mexico Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 26. Mexico Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 27. Europe Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 28. Europe Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 29. Europe Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 30. Europe Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 31. Germany Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 32. Germany Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 33. Germany Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 34. Germany Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 35. France Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 36. France Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 37. France Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 38. France Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 39. Italy Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 40. Italy Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 41. Italy Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 42. Italy Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 43. UK Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 44. UK Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 45. UK Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 46. UK Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 47. Spain Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 48. Spain Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 49. Spain Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 50. Spain Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 51. Rest of Europe Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 52. Rest of Europe Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 53. Rest of Europe Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 54. Rest of Europe Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 55. Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 56. Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 57. Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 58. Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 59. Australia Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 60. Australia Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 61. Australia Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 62. Australia Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 63. China Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 64. China Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 65. China Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 66. China Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 67. India Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 68. India Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 69. India Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 70. India Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 71. Japan Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 72. Japan Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 73. Japan Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 74. Japan Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 75. South Korea Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 76. South Korea Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 77. South Korea Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 78. South Korea Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 79. Rest of Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 80. Rest of Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 81. Rest of Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 82. Rest of Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 83. Middle East and Africa Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 84. Middle East and Africa Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 85. Middle East and Africa Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 86. Middle East and Africa Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 87. South Africa Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 88. South Africa Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 89. South Africa Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 90. South Africa Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 91. Saudi Arabia Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 92. Saudi Arabia Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 93. Saudi Arabia Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 94. Saudi Arabia Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 95. UAE Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 96. UAE Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 97. UAE Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 98. UAE Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 99. Rest of Middle East and Africa Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 100. Rest of Middle East and Africa Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 101. Rest of Middle East and Africa Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 102. Rest of Middle East and Africa Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 103. South America Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 104. South America Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 105. South America Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 106. South America Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 107. Brazil Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 108. Brazil Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 109. Brazil Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 110. Brazil Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 111. Argentina Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 112. Argentina Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 113. Argentina Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 114. Argentina Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 115. Rest of South America Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 116. Rest of South America Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 117. Rest of South America Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 118. Rest of South America Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 119. List of Abbreviation
LIST OF FIGURES
Figure 1. Manufacturing Execution System in Life Sciences Market Segmentation
Figure 2. Manufacturing Execution System in Life Sciences Market Segmentation, By Region
Figure 3. Global Manufacturing Execution System in Life Sciences Market Overview
Figure 4. Services Held Largest Share Of Offering Segment In Manufacturing Execution System in Life Sciences Market
Figure 5. On Premises Held Largest Share Of Deployment Segment In Manufacturing Execution System in Life Sciences Market
Figure 6. Large Enterprises Held Largest Share Of Organization Size Segment In Manufacturing Execution System in Life Sciences Market
Figure 7. Medical Device Held Largest Share Of Application Segment In Manufacturing Execution System in Life Sciences Market
Figure 8. Asia Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South America: PEST Analysis
Figure 14. Expert Opinion
Figure 15. Light MES in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 16. Manufacturing Execution System in Life Sciences Market: Impact Analysis of Drivers and Restraints
Figure 17. Geographic Overview of Manufacturing Execution System in Life Sciences Market
Figure 18. Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 19. MES in Life Sciences Market – Global Market Share (2022)
Figure 20. MES in Life Sciences Market – Company Market Share for Pharma/Bio-Pharma Solutions (2022)
Figure 21. MES in Life Sciences Market – Company Market Share for Pharma/Bio-Pharma Services (2022)
Figure 22. MES in Life Sciences Market – Company Market Share for Medical Devices Solutions (2022)
Figure 23. MES in Life Sciences Market – Company Market Share for Medical Devices Services (2022)
Figure 24. Manufacturing Execution System in Life Sciences Market Revenue Share, By Offering (2022 and 2033)
Figure 25. Software: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 26. Services: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 27. Manufacturing Execution System in Life Sciences Market Revenue Share, By Deployment (2022 and 2033)
Figure 28. On-Premises: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 29. Cloud: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 30. Manufacturing Execution System in Life Sciences Market Revenue Share, By Organization Size (2022 and 2033)
Figure 31. SMEs: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 32. Large Enterprises: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 33. Manufacturing Execution System in Life Sciences Market Revenue Share, By Application (2022 and 2033)
Figure 34. Pharmaceutical: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 35. Biotechnology: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 36. Medical Devices: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 37. North America: Manufacturing Execution System in Life Sciences Market, by Key Country – Revenue (2022) (US$ Million)
Figure 38. North America Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 39. US: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 40. Canada: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 41. Mexico: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 42. Europe: Manufacturing Execution System in Life Sciences Market, by Key Country – Revenue (2022) (US$ Million)
Figure 43. Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 44. Germany: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 45. France: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 46. Italy: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 47. UK: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 48. Spain: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 49. Rest of Europe: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 50. Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Key Country – Revenue (2022) (US$ Million)
Figure 51. Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 52. Australia: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 53. China: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 54. India: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 55. Japan: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 56. South Korea: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 57. Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 58. Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Key Country – Revenue (2022) (US$ Million)
Figure 59. Middle East and Africa Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 60. South Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 61. Saudi Arabia: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 62. UAE: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 63. Rest of Middle East & Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 64. South America: Manufacturing Execution System in Life Sciences Market, by Key Country – Revenue (2022) (US$ Million)
Figure 65. South America Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 66. Brazil: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 67. Argentina: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 68. Rest of South & Central America: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
The List of Companies - Manufacturing Execution System in Life Sciences Market
- Korber AG
- Siemens AG
- Emerson Electric
- Schneider Electric
- Rockwell Automation
- Apprentice FS Inc
- ATS Global
- Atachi Systems
- LZ Lifescience Ltd
- POMS Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Manufacturing Execution System in Life Sciences Market
Mar 2023
Flight Planning Software Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Software and Services), Deployment (Cloud and On-Premise), Application (Logistics and Cargo, Airport, Private Airlines, Commercial Airlines, Flight School and Training Center, and Military and Defense), and Geography
Mar 2023
Deepfake AI Detection Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Software and Services), Deployment (Cloud and On-Premises), Enterprise Size (Large Enterprises and SMEs), Industry Vertical (Media and Entertainment, BFSI, Government and Politics, Healthcare and Life Sciences, IT and Telecom, Retail and E-Commerce, and Others), and Geography
Mar 2023
Environmental Consulting Service Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Investment Assessment and Auditing, Permitting and Compliance, Project and Information Management, Monitoring and Testing, and Others), Media Type (Water Management, Waste Management, and Others), Vertical (Energy and Utilities, Chemical and Petroleum, Manufacturing and Process Industries, Transportation and Construction Industries, and Others), and Geography
Mar 2023
Cloud OSS BSS Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By solution [OSS (Network Management & Orchestration, Resource Management, Analytics & Assurance, and Service Design & Fulfilment) and BSS (Billing & Revenue Management, Product Management, Customer Management, and Others)], Deployment Model (Public Cloud, Private Cloud, and Hybrid Cloud), Enterprise Size (Small & Medium Enterprises and Large Enterprises), and Industry (IT & Telecom, BFSI, Media & Entertainment, Healthcare, and Others), and Geography
Mar 2023
Unified Endpoint Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Solutions and Services), Deployment Type (Cloud-Based and On-Premise), Platform (Desktop and Mobile), Organization Size (Large Enterprises and SMEs), End User (BFSI, Government and Defense, Healthcare, IT and Telecom, Automotive and Transportation, Retail, Manufacturing, and Others), and Geography
Mar 2023
AI in Computer Vision Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Software and Hardware) and End Use Industry (Security and Surveillance, Manufacturing, Automotive, Retail, Sports and Entertainment, and Others), and Geography
Mar 2023
Automotive Dealer Management System Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Software and Services), Application (Inventory Management, Appointment Scheduling, Customer Relationship Management, Dealer Tracking, and Others), Deployment (Cloud-Based and On-Premise), and Geography
Mar 2023
Electronic Data Interchange Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Solution and Services), Type (Direct Electronic Data Interchange, Electronic Data Interchange via AS2, Electronic Data Interchange via VAN, Mobile Electronic Data Interchange, Web Electronic Data Interchange, Electronic Data Interchange Outsourcing, and Others), Industry (BFSI, Retail & Consumer Goods, Healthcare, IT & Telecommunication, Transportation & Logistics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For